Fresenius Kabi, a company based in Bad Homburg, Germany, announced that its Fenwal Amicus Red Blood Cell Exchange (RBCx) system won clearance from the FDA. The device can automatically remove patient’s blood cells and replace them with another fluid, particularly useful when treating sickle cell disease. The system can perform exchange, depl (Read more...)